Gene therapy development shows long term benefit for treating rare blindness

The EME Programme has funded further research into a pioneering gene therapy to treat a rare form of blindness after previous research found that the technique has helped improve the vision of some patients for as long as four years. A technique which involves injecting a virus into the eye to deliver billions of healthy...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news